‘Prototypical’ proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting-Reference-Cited by-同舟云学术

‘Prototypical’ proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting

Published:2020-01-02 Issue:1 Volume:24 Page:37-46
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Musella Alessandra¹²,Fresegna Diego¹,Rizzo Francesca Romana³,Gentile Antonietta¹³,De Vito Francesca⁴,Caioli Silvia³,Guadalupi Livia³,Bruno Antonio³,Dolcetti Ettore³,Buttari Fabio⁴,Bullitta Silvia³,Vanni Valentina¹,Centonze Diego³⁴,Mandolesi Georgia¹²

Affiliation:

1. Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, Rome, Italy

2. San Raffaele University, Rome, Italy

3. Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, Rome, Italy

4. Unit of Neurology, IRCCS Neuromed, Pozzilli, IS, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1709823

Reference99 articles.